Form 8-K ImmunoCellular Therapeut For: Aug 07
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140807/AL2Z2G2FZ22RHZZ2222U2ZXPOSP2ZZ223I62
Filed on: August 7, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prospect Floating Rate and Alternative Income Fund Announces a 14.96% Annualized Total Cash Common Shareholder Distribution Rate on Net Asset Value for June 2026
- KULR Technology Group Chairman and CEO Michael Mo Releases Shareholder Letter
- JPMorganChase Announces 2026 Dodd-Frank Act Stress Test Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
